These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9363347)

  • 1. Economic evaluation of dorzolamide vs. pilocarpine for primary open-angle glaucoma.
    Rocchi A; Tingey D
    Can J Ophthalmol; 1997 Oct; 32(6):414-8. PubMed ID: 9363347
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma.
    D'Andrea A; D'Andrea D; Ferreri G
    Acta Ophthalmol Scand Suppl; 1998; (227):36-8. PubMed ID: 9972339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A topical carbonic anhydrase inhibitor finally arrives.
    Palmberg P
    Arch Ophthalmol; 1995 Aug; 113(8):985-6. PubMed ID: 7639673
    [No Abstract]   [Full Text] [Related]  

  • 5. 2% dorzolamide and cornea: an ultrabiomicroscopic study.
    Uva MG; Russo V; Longo A; Ott JP; Reibaldi A
    Acta Ophthalmol Scand Suppl; 1997; (224):23-4. PubMed ID: 9589715
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical carbonic anhydrase inhibitors.
    Talluto DM; Wyse TB; Krupin T
    Curr Opin Ophthalmol; 1997 Apr; 8(2):2-6. PubMed ID: 10168353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.
    Manni GL; Centofanti M; Napoli D; Parisi V; Bucci MG
    Acta Ophthalmol Scand Suppl; 1997; (224):22-3. PubMed ID: 9589714
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
    Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K; Snyder E; Adamsons I
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N; Grehn F; Hennekes R; Garus H
    Fortschr Ophthalmol; 1990; 87(2):128-30. PubMed ID: 2192972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Additive effects of topical carbonic anhydrase inhibitors].
    Potocký M
    Cesk Slov Oftalmol; 2001 Jul; 57(4):250-4. PubMed ID: 11512439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
    Stewart WC; Halper LK; Johnson-Pratt L; Polis A; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Azarga, a new and useful fixed combination in glaucoma treatment].
    Călugăru M; Călugăru D
    Oftalmologia; 2011; 55(3):38-46. PubMed ID: 22428291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K
    Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical carbonic anhydrase inhibitors for glaucoma].
    Geyer O; Michaeli-Cohen A
    Harefuah; 1996 May; 130(10):705-7. PubMed ID: 8794665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.